Brief: Newron Starts Clinical Trial With Evenamide In Schizophrenia Patients

Newron Pharmaceuticals SpA

09/01/2020 06:02

Jan 9 (Reuters) - NEWRON PHARMACEUTICALS SPA  NWRN.S :
    * ANNOUNCES INITIATION OF NEW CLINICAL TRIAL WITH EVENAMIDE
IN
PATIENTS WITH SCHIZOPHRENIA, FOLLOWING APPROVAL OF PLAN BY FDA
    * EXPECTS INITIAL RESULTS FROM ADDITIONAL STUDIES IN RATS
AND
HUMANS IN Q3 2020
    * WE EXPECT TO SUBMIT INITIAL RESULTS TO FDA IN Q3 2020, AND
RESULTS FROM NEXT STUDY IN PATIENTS IN Q4 2020
    * ACCEPTANCE OF RESULTS FROM STUDIES IN HUMANS AND
TOXICOLOGY
STUDIES TO ALLOW TO START PHASE III CLINICAL PROGRAM SHORTLY
THEREAFTER

Source text for Eikon:  ID:nEQ4BZNFva 
Further company coverage:  NWRN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))